Publications by authors named "Andrew G Geiser"

Claim this Profile
N
Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroids.
Timothy I Richardson, Christian A Clarke, Kuo-Long Yu, Ying K Yee, Thomas J Bleisch, Andrew G Geiser

ACS Med Chem Lett· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model.
David E Komatsu, Kellie A Brune, Hong Liu, Allen L Schmidt, Bomie Han, Andrew G Geiser

Endocrinology· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity.
Bomie Han, Marci Copeland, Andrew G Geiser, Laura V Hale, Anita Harvey

J Proteome Res· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safety.
Timothy I Richardson, Scott A Frank, Minmin Wang, Christian A Clarke, Scott A Jones, Andrew G Geiser

Bioorg Med Chem Lett· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
Tao Wei, Andrew G Geiser, Hui-Rong Qian, Chen Su, Leah M Helvering

BMC Womens Health· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of the human ADAMTS-4 promoter by transcription factors and cytokines.
Kannan Thirunavukkarasu, Yong Pei, Terry L Moore, He Wang, Xiao-Peng Yu, Andrew G Geiser

Biochem Biophys Res Commun· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A selective estrogen receptor modulator for the treatment of hot flushes.
Owen B Wallace, Kenneth S Lauwers, Jeffrey A Dodge, Scott A May, Joel R Calvin, Andrew G Geiser

J Med Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
Conrad W Hummel, Andrew G Geiser, Henry U Bryant, Ilene R Cohen, Robert D Dally

J Med Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation.
Andrew G Geiser, Conrad W Hummel, Michael W Draper, Judith W Henck, Ilene R Cohen

Endocrinology· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzothiophene and naphthalene derived constrained SERMs.
Owen B Wallace, Henry U Bryant, Pamela K Shetler, Mary D Adrian, Andrew G Geiser

Bioorg Med Chem Lett· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling.
Venkatesh Krishnan, Terry L Moore, Yanfei L Ma, Leah M Helvering, Charles A Frolik, Andrew G Geiser

Mol Endocrinol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis